These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 18084691
1. Effect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trial. von Mühlen D, Laughlin GA, Kritz-Silverstein D, Bergstrom J, Bettencourt R. Osteoporos Int; 2008 May; 19(5):699-707. PubMed ID: 18084691 [Abstract] [Full Text] [Related]
2. Sex-specific effects of dehydroepiandrosterone (DHEA) on bone mineral density and body composition: A pooled analysis of four clinical trials. Jankowski CM, Wolfe P, Schmiege SJ, Nair KS, Khosla S, Jensen M, von Muhlen D, Laughlin GA, Kritz-Silverstein D, Bergstrom J, Bettencourt R, Weiss EP, Villareal DT, Kohrt WM. Clin Endocrinol (Oxf); 2019 Feb; 90(2):293-300. PubMed ID: 30421439 [Abstract] [Full Text] [Related]
3. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men. Villareal DT, Holloszy JO, Kohrt WM. Clin Endocrinol (Oxf); 2000 Nov; 53(5):561-8. PubMed ID: 11106916 [Abstract] [Full Text] [Related]
4. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. Gordon CM, Grace E, Emans SJ, Feldman HA, Goodman E, Becker KA, Rosen CJ, Gundberg CM, LeBoff MS. J Clin Endocrinol Metab; 2002 Nov; 87(11):4935-41. PubMed ID: 12414853 [Abstract] [Full Text] [Related]
5. Effects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trial. Jankowski CM, Gozansky WS, Schwartz RS, Dahl DJ, Kittelson JM, Scott SM, Van Pelt RE, Kohrt WM. J Clin Endocrinol Metab; 2006 Aug; 91(8):2986-93. PubMed ID: 16735495 [Abstract] [Full Text] [Related]
6. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS. Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338 [Abstract] [Full Text] [Related]
7. Dehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on bone. Weiss EP, Shah K, Fontana L, Lambert CP, Holloszy JO, Villareal DT. Am J Clin Nutr; 2009 May; 89(5):1459-67. PubMed ID: 19321570 [Abstract] [Full Text] [Related]
8. A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA supplementation of bone mineral density in healthy adults. Lin H, Li L, Wang Q, Wang Y, Wang J, Long X. Gynecol Endocrinol; 2019 Nov; 35(11):924-931. PubMed ID: 31237150 [Abstract] [Full Text] [Related]
9. Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens. Jankowski CM, Gozansky WS, Kittelson JM, Van Pelt RE, Schwartz RS, Kohrt WM. J Clin Endocrinol Metab; 2008 Dec; 93(12):4767-73. PubMed ID: 18812486 [Abstract] [Full Text] [Related]
10. Effect of DHEA supplementation on serum IGF-1, osteocalcin, and bone mineral density in postmenopausal, glucocorticoid-treated women. Papierska L, Rabijewski M, Kasperlik-Załuska A, Zgliczyński W. Adv Med Sci; 2012 Jun 01; 57(1):51-7. PubMed ID: 22430044 [Abstract] [Full Text] [Related]
11. The Dehydroepiandrosterone And WellNess (DAWN) study: research design and methods. von Mühlen D, Laughlin GA, Kritz-Silverstein D, Barrett-Connor E. Contemp Clin Trials; 2007 Feb 01; 28(2):153-68. PubMed ID: 16784898 [Abstract] [Full Text] [Related]
12. DHEA in elderly women and DHEA or testosterone in elderly men. Nair KS, Rizza RA, O'Brien P, Dhatariya K, Short KR, Nehra A, Vittone JL, Klee GG, Basu A, Basu R, Cobelli C, Toffolo G, Dalla Man C, Tindall DJ, Melton LJ, Smith GE, Khosla S, Jensen MD. N Engl J Med; 2006 Oct 19; 355(16):1647-59. PubMed ID: 17050889 [Abstract] [Full Text] [Related]
13. Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial. Lems WF, Lodder MC, Lips P, Bijlsma JW, Geusens P, Schrameijer N, van de Ven CM, Dijkmans BA. Osteoporos Int; 2006 Oct 19; 17(5):716-23. PubMed ID: 16463007 [Abstract] [Full Text] [Related]
14. Efficacy and safety of monthly ibandronate in men with low bone density. Orwoll ES, Binkley NC, Lewiecki EM, Gruntmanis U, Fries MA, Dasic G. Bone; 2010 Apr 19; 46(4):970-6. PubMed ID: 20060082 [Abstract] [Full Text] [Related]
15. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis. Li M, Zhang ZL, Liao EY, Chen DC, Liu J, Tao TZ, Wu W, Xia WB, Lu YJ, Sheng ZF, Lu CY, Meng GL, Xu L, Zhang WJ, Hu YY, Xu L. Menopause; 2013 Jan 19; 20(1):72-8. PubMed ID: 22968256 [Abstract] [Full Text] [Related]
16. Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover. Gürlek A, Gedik O. J Endocrinol Invest; 2001 Jun 19; 24(6):408-14. PubMed ID: 11434664 [Abstract] [Full Text] [Related]
17. Effects of dehydroepiandrosterone on bone mineral density: what implications for therapy? Villareal DT. Treat Endocrinol; 2002 Jun 19; 1(6):349-57. PubMed ID: 15832488 [Abstract] [Full Text] [Related]
18. Effect of dehydroepiandrosterone on bone mass, serum lipids, and dimethylbenz(a)anthracene-induced mammary carcinoma in the rat. Luo S, Labrie C, Bélanger A, Labrie F. Endocrinology; 1997 Aug 19; 138(8):3387-94. PubMed ID: 9231792 [Abstract] [Full Text] [Related]
19. Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial. Prestwood KM, Kenny AM, Kleppinger A, Kulldorff M. JAMA; 2003 Aug 27; 290(8):1042-8. PubMed ID: 12941676 [Abstract] [Full Text] [Related]
20. An investigation of the predictors of bone mineral density and response to therapy with alendronate in osteoporotic men. Drake WM, Kendler DL, Rosen CJ, Orwoll ES. J Clin Endocrinol Metab; 2003 Dec 27; 88(12):5759-65. PubMed ID: 14671165 [Abstract] [Full Text] [Related] Page: [Next] [New Search]